Your browser doesn't support javascript.
loading
Drug Tolerant Anti-drug Antibody Assay for Infliximab Treatment in Clinical Practice Identifies Positive Cases Earlier.
Kharlamova, Nastya; Hermanrud, Christina; Dunn, Nicky; Ryner, Malin; Hambardzumyan, Karen; Vivar Pomiano, Nancy; Marits, Per; Gjertsson, Inger; Saevarsdottir, Saedis; Pullerits, Rille; Fogdell-Hahn, Anna.
Affiliation
  • Kharlamova N; Department of Clinical Neuroscience, Karolinska Institutet, Stockholm, Sweden.
  • Hermanrud C; Center for Molecular Medicine, Stockholm, Sweden.
  • Dunn N; Department of Clinical Neuroscience, Karolinska Institutet, Stockholm, Sweden.
  • Ryner M; Center for Molecular Medicine, Stockholm, Sweden.
  • Hambardzumyan K; Department of Clinical Neuroscience, Karolinska Institutet, Stockholm, Sweden.
  • Vivar Pomiano N; Center for Molecular Medicine, Stockholm, Sweden.
  • Marits P; Department of Clinical Neuroscience, Karolinska Institutet, Stockholm, Sweden.
  • Gjertsson I; Center for Molecular Medicine, Stockholm, Sweden.
  • Saevarsdottir S; Rheumatology Division, Department of Medicine, Solna, Karolinska Institutet, Stockholm, Sweden.
  • Pullerits R; Rheumatology Division, Department of Medicine, Solna, Karolinska Institutet, Stockholm, Sweden.
  • Fogdell-Hahn A; Department of Clinical Immunology and Transfusion Medicine, Karolinska University Hospital, Stockholm, Sweden.
Front Immunol ; 11: 1365, 2020.
Article de En | MEDLINE | ID: mdl-32793189

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Dosage immunologique / Anticorps anti-idiotypiques / Rhumatismes / Antirhumatismaux / Tolérance aux médicaments / Infliximab Type d'étude: Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limites: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Langue: En Journal: Front Immunol Année: 2020 Type de document: Article Pays d'affiliation: Suède Pays de publication: Suisse

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Dosage immunologique / Anticorps anti-idiotypiques / Rhumatismes / Antirhumatismaux / Tolérance aux médicaments / Infliximab Type d'étude: Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limites: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Langue: En Journal: Front Immunol Année: 2020 Type de document: Article Pays d'affiliation: Suède Pays de publication: Suisse